240008 people have viewed this drug in the last 60 days
Updated 2025-10-03
Last Update | 2022-08-31 |
Register Year | 2016 |
Product Type | Human |
Drug Type | Biological |
Scientific Name | AGALSIDASE BETA |
Trade Name | FABRAZYME 35 mg powder for concentrate for solution for infusion |
Strength Unit | mg/ml |
Pharmaceutical Form | Powder for concentrate for solution for infusion |
Administration Route | Intravenous use |
Atc Code1 | A16AB04 |
Atc Code2 | |
Size | 7 |
Size Unit | ml |
Package Types | Vial |
Package Size | 1 |
Legal Status | Prescription |
Product Control | Uncontrolled |
Distribute Area | Hospital |
Public price | $14909.65 |
Shelf Life | 36 Months |
Marketing Company | GENZYME EUROPE B.V. |
Marketing Country | Netherlands |
Manufacture Name | GENZYME IRELAND LIMITED |
Manufacture Country | Ireland |
Secondry package manufacture | |
Main Agent | Sanofi Arabia Trading Co. Ltd |
Secosnd Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
Third Agent | |
Visits | 240008 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
Name | Price | Visits | Updated |
---|---|---|---|
FABRAZYME 5 mg powder for concentrate fo | $2129.95 | 75112 visits | 2022-08-31 |
FABRAZYME 35 mg powder for concentrate f | $14909.65 | 240008 visits | 2022-08-31 |